{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:35:59Z","timestamp":1790501759240,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007020.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:00:00Z","timestamp":1570060800000}}],"reference-count":169,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007020.pub4","type":"journal-article","created":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T10:17:06Z","timestamp":1570097826000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Antioxidant supplementation for lung disease in cystic fibrosis"],"prefix":"10.1002","volume":"2019","author":[{"given":"Oana","family":"Ciofu","sequence":"first","affiliation":[{"name":"University of Copenhagen; Department of International Health, Immunology and Microbiology; Blegdamsvej 3 Copenhagen Denmark 2200"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherie","family":"Smith","sequence":"additional","affiliation":[{"name":"University of Nottingham; Division of Child Health, Obstetrics & Gynaecology (COG), School of Medicine; 1701 E Floor East Block Queens Medical Centre Nottingham NG7 2UH UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Lykkesfeldt","sequence":"additional","affiliation":[{"name":"University of Copenhagen; Department of Veterinary Disease Biology, Experimental Animal Models; Ridebanevej 9 Copenhagen Denmark 1870 Frb."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,10,3]]},"reference":[{"key":"10.1002\/14651858.CD007020.pub4-BIB0001|cit1","first-page":"267","article-title":"Glutathione augmentation in cystic fibrosis","volume":"Suppl 25","author":"Bishop","year":"2003","journal-title":"Pediatric Pulmonology"},{"issue":"1","key":"10.1002\/14651858.CD007020.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1378\/chest.127.1.308","article-title":"A pilot study of the effect of inhaled buffered reduced glutathione on the clinical status of patients with cystic fibrosis","volume":"127","author":"Bishop","year":"2005","journal-title":"Chest"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0003|cit3","first-page":"S30","article-title":"Effect of inhaled buffered reduced glutathione (GSH) on the clinical status of cystic fibrosis patients","volume":"3 Suppl 1","author":"Bishop","year":"2004","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0004|cit4","first-page":"D041 Poster","article-title":"Effect of inhaled buffered reduced glutathione (GSH) on the clinical status of cystic fibrosis patients","volume":"167","author":"Bishop","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0005|cit5","first-page":"316s","article-title":"Inhaled glutathione tolerability and efficacy in patients with cystic fibrosis","volume":"40 Suppl 56","author":"Calabrese","year":"2012","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1-16. Online su","DOI":"10.1016\/j.jcf.2014.09.014","article-title":"Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis","volume":"14","author":"Calabrese","year":"2015","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jcf.2014.09.014","article-title":"Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis","volume":"14","author":"Calabrese","year":"2015","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S1569-1993(12)60220-3","article-title":"Inhaled GSH tolerability in patients with cystic fibrosis (CF)","volume":"11 Suppl 1","author":"Casale","year":"2012","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0009|cit9","first-page":"316s","article-title":"Inhaled glutathione tolerability and efficacy in patients with cystic fibrosis","volume":"40 Suppl 56","author":"Calabrese","year":"2012","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1-16. Online su","DOI":"10.1016\/j.jcf.2014.09.014","article-title":"Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis","volume":"14","author":"Calabrese","year":"2015","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jcf.2014.09.014","article-title":"Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis","volume":"14","author":"Calabrese","year":"2015","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S1569-1993(12)60220-3","article-title":"Inhaled GSH tolerability in patients with cystic fibrosis (CF)","volume":"11 Suppl 1","author":"Casale","year":"2012","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0013|cit13","first-page":"316s","article-title":"Inhaled glutathione tolerability and efficacy in patients with cystic fibrosis","volume":"40 Suppl 56","author":"Calabrese","year":"2012","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1-16.Onlne supp","DOI":"10.1016\/j.jcf.2014.09.014","article-title":"Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis","volume":"14","author":"Calabrese","year":"2015","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jcf.2014.09.014","article-title":"Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis","volume":"14","author":"Calabrese","year":"2015","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S1569-1993(12)60220-3","article-title":"Inhaled GSH tolerability in patients with cystic fibrosis (CF)","volume":"11 Suppl 1","author":"Casale","year":"2012","journal-title":"Journal of Cystic Fibrosis"},{"issue":"2","key":"10.1002\/14651858.CD007020.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jcf.2014.08.008","article-title":"Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial","volume":"14","author":"Conrad","year":"2015","journal-title":"Journal of Cystic Fibrosis"},{"issue":"2","key":"10.1002\/14651858.CD007020.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"219-27. Online","DOI":"10.1016\/j.jcf.2014.08.008","article-title":"Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial","volume":"14","author":"Conrad","year":"2015","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0019|cit19","unstructured":"NCT00809094 NAC phase IIB: a multi-center, phase IIB, randomized, placebo-controlled, double-blind study of the effects of N-acetylcysteine on redox changes and lung inflammation in cystic fibrosis patients clinicaltrials.gov\/ct2\/show\/NCT00809094"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0020|cit20","first-page":"280","article-title":"A multi-center, phase iib, randomized, placebo-controlled, double-blind study of the effects of N-acetylcysteine (NAC) on redox changes and lung inflammation in cystic fibrosis patients","volume":"46 Suppl 34","author":"Tirouvanziam","year":"2011","journal-title":"Pediatric Pulmonology"},{"issue":"8","key":"10.1002\/14651858.CD007020.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/2047-783X-14-8-352","article-title":"A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis","volume":"14","author":"Dauletbaev","year":"2009","journal-title":"European Journal of Medical Research"},{"issue":"Suppl 111","key":"10.1002\/14651858.CD007020.pub4-BIB0022|cit22","first-page":"122","article-title":"Oral acetylcysteine in cystic fibrosis. A co-operative study","volume":"61","author":"G\u00f6tz","year":"1980","journal-title":"European Journal of Respiratory Diseases"},{"issue":"3","key":"10.1002\/14651858.CD007020.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jcf.2016.12.002","article-title":"Increasing sputum levels of gamma-glutamyltransferase may identify cystic fibrosis patients who do not benefit from inhaled glutathione","volume":"16","author":"Corti","year":"2017","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S1569-1993(12)60034-4","article-title":"Inhaled glutathione in cystic fibrosis","volume":"11 Suppl 1","author":"Griese","year":"2012","journal-title":"Journal of Cystic Fibrosis"},{"issue":"1","key":"10.1002\/14651858.CD007020.pub4-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1164\/rccm.201303-0427OC","article-title":"Inhalation treatment with glutathione in patients with cystic fibrosis: a randomized clinical trial","volume":"188","author":"Griese","year":"2013","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"247","key":"10.1002\/14651858.CD007020.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/adc.46.247.341","article-title":"Absorption of different doses of fat soluble and water miscible preparations of vitamin E in children with cystic fibrosis","volume":"46","author":"Harries","year":"1971","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0027|cit27","unstructured":"Harries JT Muller DP Absorption of water miscible and fat soluble preparations of vitamin E in cystic fibrosis Proceedings of the 5th International Cystic Fibrosis Conference; 1969 Sept 22-26; Cambridge, England 1969 298 307"},{"issue":"3","key":"10.1002\/14651858.CD007020.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0022-3476(95)70089-7","article-title":"Single- and multiple-dose-response relationships of beta-carotene in cystic fibrosis","volume":"127","author":"Homnick","year":"1995","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD007020.pub4-BIB0029|cit29","first-page":"82","article-title":"A double-blind study of the use of acetylcysteine in patients with cystic fibrosis","volume":"32","author":"Howatt","year":"1966","journal-title":"University of Michigan Medical Center Journal"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0030|cit30","unstructured":"Kelijo DJ Giroir B Jialal I Circulating tumor necrosis factor-alpha and IL-6 levels in patients with cystic fibrosis and mild lung disease: effects of dnase and alpa-tocopherol therapy [personal communication] Unpublished article"},{"issue":"Suppl 20","key":"10.1002\/14651858.CD007020.pub4-BIB0031|cit31","first-page":"326","article-title":"Circulating tumor necrosis factor alpha and interleukin-6 levels in cystic fibrosis, effect of vitamin E therapy","volume":"30","author":"Keljo","year":"2000","journal-title":"Pediatric Pulmonology"},{"issue":"3","key":"10.1002\/14651858.CD007020.pub4-BIB0033|cit32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/adc.49.3.247-a","article-title":"Letter: Muscular performance and vitamin E in cystic fibrosis","volume":"49","author":"Levin","year":"1974","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0032|cit33","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1542\/peds.27.4.578","article-title":"Studies of tocopherol deficiency in infants and children: VI. Evaluation of muscle strength and effect of tocopherol administration in children with cystic fibrosis","volume":"27","author":"Levin","year":"1961","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD007020.pub4-BIB0034|cit34","first-page":"40","article-title":"Controlled trial of oral N-acetylcysteine in cystic fibrosis","volume":"18","author":"Mitchell","year":"1982","journal-title":"Australian Paediatric Journal"},{"issue":"1-2","key":"10.1002\/14651858.CD007020.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0009-8981(94)05991-Z","article-title":"Effect of double-blind cross-over selenium supplementation on lipid peroxidation markers in cystic fibrosis patients","volume":"34","author":"Portal","year":"1995","journal-title":"Clinica Chimica Acta (International Journal of Clinical Chemistry)"},{"issue":"6","key":"10.1002\/14651858.CD007020.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/clinchem\/39.6.1023","article-title":"Effect of double-blind crossover selenium supplementation on biological indices of selenium status in cystic fibrosis patients","volume":"39","author":"Portal","year":"1993","journal-title":"Clinical Chemistry"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0037|cit37","unstructured":"Ratjen F Posselt HG W\u00f6nne R St\u00f6ver B Bender SW A double-blind placebo controlled trial with ambroxol and N-Acetylcysteine for mucolytic treatment in cystic fibrosis 9th International Cystic Fibrosis Congress; 1984 June 9-15; Brighton, England 1984"},{"issue":"4","key":"10.1002\/14651858.CD007020.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF00441781","article-title":"A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis","volume":"144","author":"Ratjen","year":"1985","journal-title":"European Journal of Pediatrics"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0039|cit39","first-page":"S134","article-title":"Bioavailability of therapeutic beta-carotene (BC) in patients with cystic fibrosis (CF) and effects on anthropometrical parameters over 6 months","volume":"145","author":"Engl","year":"1997","journal-title":"Monatsschrift fur Kinderheilkunde"},{"issue":"1","key":"10.1002\/14651858.CD007020.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/thorax.56.1.48","article-title":"Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis","volume":"56","author":"Renner","year":"2001","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0041|cit41","unstructured":"Renner S Wojnarowski C Koller DY Rust P Elmadfa I Eichler I Patients with cystic fibrosis (CF) benefit from \u03b2-Carotene supplementation for 6 months 22nd European Cystic Fibrosis Conference; 1998 June 13-19; Berlin, Germany 1998 97"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0042|cit42","first-page":"314","article-title":"Patients with cystic fibrosis (CF) benefit from \u03b2-Carotene supplementation for 6 months","volume":"24 Suppl 15","author":"Renner","year":"1997","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0043|cit43","first-page":"51","article-title":"Influence of an oral beta-carotine-supplementation on the antioxidant status of patients with cystic fibrosis","volume":"23","author":"Rust","year":"1997","journal-title":"Atemwegs und Lungenkrankheiten"},{"issue":"2","key":"10.1002\/14651858.CD007020.pub4-BIB0044|cit44","first-page":"83","article-title":"Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis","volume":"68","author":"Rust","year":"1998","journal-title":"International Journal for Vitamin and Nutrition Research"},{"issue":"1","key":"10.1002\/14651858.CD007020.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000012818","article-title":"Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function","volume":"44","author":"Rust","year":"2000","journal-title":"Annals of Nutrition & Metabolism"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0046|cit46","first-page":"262","article-title":"Biomarkers of inflammation and oxidative stress in CF: implications for antiinflammatory drug development","volume":"51 Suppl 45","author":"Jain","year":"2016","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0047|cit47","unstructured":"NCT01859390 Effects of an antioxidant-enriched multivitamin supplement on inflammation and oxidative stress in cystic fibrosis (AquADEKs-2) clinicaltrials.gov\/ct2\/show\/NCT01859390"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0048|cit48","first-page":"283","article-title":"Effects of an antioxidant-enriched multivitamin supplement on inflammation and oxidative stress in CF","volume":"51 Suppl 45","author":"Sagel","year":"2016","journal-title":"Pediatric Pulmonology"},{"issue":"5","key":"10.1002\/14651858.CD007020.pub4-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1164\/rccm.201801-0105OC","article-title":"Effects of an antioxidant-enriched multivitamin in cystic fibrosis: randomized, controlled, multicenter trial","volume":"198","author":"Sagel","year":"2018","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0050|cit50","doi-asserted-by":"crossref","unstructured":"Stafanger G Garne S Howitz P Koch C Effect of peroral N-acetylcysteine in patients with cystic fibrosis and primary cilia dyskinesia 14th Annual Meeting of the European Working Group for Cystic Fibrosis; 1986 Sept 1-2; Budapest, Hungary 1986 129","DOI":"10.1183\/09031936.93.01020161"},{"issue":"2","key":"10.1002\/14651858.CD007020.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1183\/09031936.93.01020161","article-title":"The clinical effect and effect on the ciliary motility of oral n-acetylcysteine in patients with cystic fibrosis and primary ciliary dyskinesia","volume":"1","author":"Stafanger","year":"1988","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0052|cit52","first-page":"R(c)29","article-title":"The effect of oral Nacteylcysteine on lung function CF patients","volume":"74","author":"Stafanger","year":"1988","journal-title":"Excerpta Medica, Asia Pacific Congress Series"},{"issue":"3","key":"10.1002\/14651858.CD007020.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1183\/09031936.93.02030234","article-title":"N-acetylcysteine in cystic fibrosis and Pseudomonas aeruginosa infection: clinical score, spirometry and ciliary motility","volume":"2","author":"Stafanger","year":"1989","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0055|cit54","unstructured":"Data and Supplementary Materials, Visca et al 2012 Trial uvicf.org\/researchnewsite\/glutathionenewsite\/ViscaTrial_Data_and_SupplementaryMaterial.html"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0054|cit55","first-page":"407","article-title":"Oral reduced L-glutathione improves nutritional status and pulmonary function in pediatric cystic fibrosis patients","volume":"48 Suppl 36","author":"Bishop","year":"2013","journal-title":"Pediatric Pulmonology"},{"issue":"6","key":"10.1002\/14651858.CD007020.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/MPG.0000000000000738","article-title":"Oral reduced L-glutathione improves growth in pediatric cystic fibrosis patients","volume":"60","author":"Visca","year":"2015","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/S1569-1993(13)60204-0","article-title":"Oral reduced L-glutathione improves weight and calprotectin in pediatric cystic fibrosis patients","volume":"12 Suppl 1","author":"Visca","year":"2013","journal-title":"Journal of Cystic Fibrosis"},{"issue":"1","key":"10.1002\/14651858.CD007020.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ajcn\/77.1.150","article-title":"Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function","volume":"77","author":"Wood","year":"2003","journal-title":"American Journal of Clinical Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD007020.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ppul.20771","article-title":"Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis","volume":"43","author":"Abdulhamid","year":"2008","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0060|cit60","first-page":"348","article-title":"Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis","volume":"40 Suppl 28","author":"Abdulhamid","year":"2005","journal-title":"Pediatric Pulmonology"},{"issue":"17","key":"10.1002\/14651858.CD007020.pub4-BIB0061|cit61","first-page":"69","article-title":"Vitamin E","volume":"17","author":"Anonymous","year":"1975","journal-title":"Medical Letter on Drugs and Therapeutics"},{"issue":"1354","key":"10.1002\/14651858.CD007020.pub4-BIB0062|cit62","first-page":"557","article-title":"Dietary management of cystic fibrosis","volume":"225","author":"Beddoes","year":"1981","journal-title":"Practitioner"},{"issue":"1","key":"10.1002\/14651858.CD007020.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.metabol.2003.07.017","article-title":"Copper enzyme activities in cystic fibrosis before and after copper supplementation plus or minus zinc","volume":"53","author":"Best","year":"2004","journal-title":"Metabolism: Clinical and Experimental"},{"issue":"12","key":"10.1002\/14651858.CD007020.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1440-1754.2005.00755.x","article-title":"Vitamin A and E deficiency and lung disease in infants with cystic fibrosis","volume":"41","author":"Bines","year":"2005","journal-title":"Journal of Paediatrics & Child Health"},{"issue":"7","key":"10.1002\/14651858.CD007020.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1651-2227.2002.tb03329.x","article-title":"Antioxidant effect of beta-carotene in cystic fibrosis and bronchiectasis: clinical and laboratory parameters of a pilot study","volume":"91","author":"Cobanoglu","year":"2002","journal-title":"Acta Paediatrica"},{"issue":"9","key":"10.1002\/14651858.CD007020.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/adc.56.9.708","article-title":"Vitamin status in treated patients with cystic fibrosis","volume":"56","author":"Congden","year":"1981","journal-title":"Archives of Disease in Childhood"},{"issue":"4","key":"10.1002\/14651858.CD007020.pub4-BIB0067|cit67","first-page":"324","article-title":"The effect of supplemental vitamin E on vitamin A serum levels in cystic fibrosis","volume":"48","author":"Ekvall","year":"1978","journal-title":"International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition"},{"issue":"1","key":"10.1002\/14651858.CD007020.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1172\/JCI108760","article-title":"The occurrence and effects of human vitamin E deficiency. A study in patients with cystic fibrosis","volume":"60","author":"Farrell","year":"1977","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0069|cit69","first-page":"32","article-title":"Practical management of nutrition and gastrointestinal tract in cystic fibrosis","volume":"79 Suppl 12","author":"Goodchild","year":"1986","journal-title":"Journal of the Royal Society of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007020.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0022-3476(95)70089-7","article-title":"Single-and multiple-dose response relationship of beta-carotene in cystic fibrosis","volume":"127","author":"Homnick","year":"1995","journal-title":"Journal of Pediatrics"},{"issue":"6680","key":"10.1002\/14651858.CD007020.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/bmj.298.6680.1098-b","article-title":"Managing adults with cystic fibrosis","volume":"298","author":"Hoogenraad","year":"1989","journal-title":"BMJ (Clinical Research Ed)"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD007020.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0022-3476(80)80685-8","article-title":"Selenium and cystic fibrosis","volume":"96","author":"Hubbard","year":"1980","journal-title":"Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD007020.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2710.2009.01027.x","article-title":"Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosis","volume":"34","author":"Jacquemin","year":"2009","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007020.pub4-BIB0074|cit74","first-page":"41","article-title":"The value of selenotherapy in patients with mucoviscidosis","volume":"90","author":"Kauf","year":"1995","journal-title":"Medizinische Klinik (Munich, Germany : 1983)"},{"issue":"12","key":"10.1002\/14651858.CD007020.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0002-8223(99)00386-7","article-title":"Research and professional briefs. Longitudinal analysis shows serum carotenoid concentrations are low in children with cystic fibrosis","volume":"99","author":"Kawchak","year":"1999","journal-title":"Journal of the American Dietetic Association"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0076|cit76","unstructured":"Kelleher J Miller MG Littlewood JM McDonald AM Losowsky The clinical effect of corrections of vitamin E depletion in cystic fibrosis International Journal for Vitamin and Nutrition Research (Internationale Zeitschrift f\u00fcr Vitamin und Ern\u00e4hrungsforschung. Journal International de Vitaminologie et de Nutrition) 1987 253 9 8506470"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0077|cit77","unstructured":"Khorasani EN Mansouri F Effect of zinc supplementation on respiratory infections in children with cystic fibrosis European Respiratory Society Annual Congress; 2009; Sept 12-16; Vienna, Austria 2009 722s"},{"issue":"4","key":"10.1002\/14651858.CD007020.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00443512","article-title":"Serum concentrations of vitamin A, carotene, retinol-binding protein and prealbumin in patients with cystic fibrosis (author's transl)","volume":"119","author":"Knopfle","year":"1975","journal-title":"Zeitschrift fur Kinderheilkunde"},{"issue":"4","key":"10.1002\/14651858.CD007020.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF02002713","article-title":"Deficiency of vitamins E and A in cystic fibrosis is independent of pancreatic function and current enzyme and vitamin supplementation","volume":"155","author":"Lancellotti","year":"1996","journal-title":"European Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD007020.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/ajcn\/64.1.87","article-title":"Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis [corrected] [published erratum appears in American Journal of Clinical Nutrition 1997 Feb; 65(2): 578]","volume":"64","author":"Lepage","year":"1996","journal-title":"American Journal of Clinical Nutrition"},{"issue":"5-6","key":"10.1002\/14651858.CD007020.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000046685","article-title":"Antioxidant status in patients with cystic fibrosis","volume":"44","author":"Madarasi","year":"2000","journal-title":"Annals of Nutrition & Metabolism"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ppul.1950110712","article-title":"Nutritional assessment of infants with cystic fibrosis diagnosed through screening","volume":"7","author":"Mischler","year":"1991","journal-title":"Pediatric Pulmonology. Supplement"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/S1569-1993(10)60352-9","article-title":"A new water-soluble oral vitamin E formulation in cystic fibrosis (CF) children","volume":"9 Suppl 1","author":"Munck","year":"2010","journal-title":"Journal of Cystic Fibrosis"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD007020.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0022-3476(06)80034-X","article-title":"Correction of vitamin E deficiency with fat-soluble versus water-miscible preparations of vitamin E in patients with cystic fibrosis","volume":"122","author":"Nasr","year":"1993","journal-title":"Journal of Pediatrics"},{"issue":"7","key":"10.1002\/14651858.CD007020.pub4-BIB0085|cit85","first-page":"900","article-title":"Anti-inflammatory approaches to the treatment of cystic fibrosis lung disease: past, present and future","volume":"2","author":"Oermann","year":"2001","journal-title":"Current Opinion in Investigational Drugs"},{"issue":"1","key":"10.1002\/14651858.CD007020.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jcf.2006.05.005","article-title":"Dietary supplementation with multiple micronutrients: no beneficial effects in pediatric cystic fibrosis patients","volume":"6","author":"Oudshoorn","year":"2007","journal-title":"Journal of Cystic Fibrosis"},{"issue":"2","key":"10.1002\/14651858.CD007020.pub4-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10620-006-9489-2","article-title":"Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients","volume":"52","author":"Papas","year":"2007","journal-title":"Digestive Diseases and Sciences"},{"issue":"4","key":"10.1002\/14651858.CD007020.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00005176-199605000-00001","article-title":"Vitamin E supplementation in cystic fibrosis","volume":"22","author":"Peters","year":"1996","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD007020.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/ajcn\/61.4.843","article-title":"Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis","volume":"61","author":"Portal","year":"1995","journal-title":"American Journal of Clinical Nutrition"},{"issue":"S33","key":"10.1002\/14651858.CD007020.pub4-BIB0090|cit90","first-page":"421","article-title":"Effect of vitamin K supplementation over one year on bone health in adolescents and adults with cystic fibrosis","volume":"45","author":"Powell","year":"2010","journal-title":"Pediatric Pulmonology"},{"issue":"6","key":"10.1002\/14651858.CD007020.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5694\/j.1326-5377.1974.tb50784.x","article-title":"Inhibition of Pseudomonas aeruginosa by ascorbic acid acting singly and in combination with antimicrobials: in-vitro and in-vivo studies","volume":"1","author":"Rawal","year":"1974","journal-title":"Medical Journal of Australia"},{"issue":"4","key":"10.1002\/14651858.CD007020.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0002-8223(95)00121-2","article-title":"Oral supplementation with a high-fat, high-energy product improves nutritional status and alters serum lipids in patients with cystic fibrosis","volume":"95","author":"Rettammel","year":"1995","journal-title":"Journal of the American Dietetic Association"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-4684-5730-8_27","article-title":"Selenium and oxidant injury in patients with cystic fibrosis","volume":"264","author":"Richard","year":"1990","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"1","key":"10.1002\/14651858.CD007020.pub4-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4187\/respcare.04038","article-title":"Zinc supplementation for one year among children with cystic fibrosis does not decrease pulmonary infection","volume":"61","author":"Sharma","year":"2016","journal-title":"Respiratory Care"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1749-6632.1989.tb14916.x","article-title":"Vitamin E deficiency neuropathy in children with fat malabsorption. Studies in cystic fibrosis and chronic cholestasis","volume":"570","author":"Sokol","year":"1989","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"5","key":"10.1002\/14651858.CD007020.pub4-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00005072-198009000-00007","article-title":"Axonal dystrophy in the gracile nucleus in congenital biliary atresia and cystic fibrosis (mucoviscidosis): beneficial effect of vitamin E therapy","volume":"39","author":"Sung","year":"1980","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/978-1-4684-5730-8_84","article-title":"Rationale for antioxidant therapy in pancreatitis and cystic fibrosis","volume":"264","author":"Uden","year":"1990","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1749-6632.1972.tb27879.x","article-title":"Polyunsaturated fatty acids and tocopherol levels in patients with cystic fibrosis","volume":"203","author":"Underwood","year":"1972","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"1","key":"10.1002\/14651858.CD007020.pub4-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1203\/00006450-197201000-00004","article-title":"Blood and liver concentrations of vitamins A and E in children with cystic fibrosis of the pancreas","volume":"6","author":"Underwood","year":"1972","journal-title":"Pediatric Research"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1054-3589(08)60996-5","article-title":"Oxidative stress in cystic fibrosis: does it occur and does it matter?","volume":"38","author":"Vliet","year":"1997","journal-title":"Advances in Pharmacology (San Diego, California)"},{"issue":"6","key":"10.1002\/14651858.CD007020.pub4-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0891-5849(95)00063-4","article-title":"Impaired resistance to oxidation of low density lipoprotein in cystic fibrosis: improvement during vitamin E supplementation","volume":"19","author":"Winklhofer-Roob","year":"1995","journal-title":"Free Radical Biology & Medicine"},{"issue":"1","key":"10.1002\/14651858.CD007020.pub4-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-3476(96)70228-7","article-title":"Beta-carotene supplementation in cystic fibrosis","volume":"129","author":"Winklhofer-Roob","year":"1996","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0103|cit103","first-page":"67","article-title":"Response of vitamin E deficient patients with cystic fibrosis (CF) to oral RRR-alpha-tocopherol or all-rac-alpha-tocopheryl acetate","volume":"11 Suppl","author":"Winklhofer-Roob","year":"1992","journal-title":"Clinical Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD007020.pub4-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/ajcn\/63.5.722","article-title":"Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-alpha-tocopheryl acetate preparations","volume":"63","author":"Winklhofer-Roob","year":"1996","journal-title":"American Journal of Clinical Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD007020.pub4-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0891-5849(94)00203-V","article-title":"Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during beta-carotene supplementation in cystic fibrosis","volume":"18","author":"Winklhofer-Roob","year":"1995","journal-title":"Free Radical Biology & Medicine"},{"issue":"1","key":"10.1002\/14651858.CD007020.pub4-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1203\/00006450-199607000-00022","article-title":"Neutrophil elastase\/alpha 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral beta-carotene supplementation","volume":"40","author":"Winklhofer-Roob","year":"1996","journal-title":"Pediatric Research"},{"issue":"10","key":"10.1002\/14651858.CD007020.pub4-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1651-2227.1995.tb13512.x","article-title":"Response to oral beta-carotene supplementation in patients with cystic fibrosis: a 16-month follow-up study","volume":"84","author":"Winklhofer-Roob","year":"1995","journal-title":"Acta Paediatrica (Oslo, Norway : 1992)"},{"issue":"1","key":"10.1002\/14651858.CD007020.pub4-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00005176-199707000-00028","article-title":"Vitamin E supplementation in cystic fibrosis","volume":"25","author":"Winklhofer-Roob","year":"1997","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD007020.pub4-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/ajcn\/65.2.575","article-title":"Beta-carotene, malondialdehyde, and cystic fibrosis","volume":"65","author":"Winklhofer-Roob","year":"1997","journal-title":"American Journal of Clinical Nutrition"},{"issue":"6","key":"10.1002\/14651858.CD007020.pub4-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/ajcn\/65.6.1858","article-title":"Plasma vitamin C concentrations in patients with cystic fibrosis: evidence of associations with lung inflammation","volume":"65","author":"Winklhofer-Roob","year":"1997","journal-title":"American Journal of Clinical Nutrition"},{"issue":"6","key":"10.1002\/14651858.CD007020.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0098-2997(03)00035-9","article-title":"Effects of vitamin E and carotenoid status on oxidative stress in health and disease. Evidence obtained from human intervention studies","volume":"24","author":"Winklhofer-Roob","year":"2003","journal-title":"Molecular Aspects of Medicine"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0112|cit112","first-page":"291","article-title":"Fenretinide treatment increases long chain ceramide C24:0 and decreases short chain ceramide C16:0 levels in patients with cystic fibrosis (phase IB clinical trial)","volume":"50 Suppl 41","author":"Garic","year":"2015","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0113|cit113","first-page":"290","article-title":"A novel oral formulation of fenretinide demonstrates safety and tolerability in a phase 1B dose-ascending trial involving adult cystic fibrosis patients","volume":"50 Suppl 41","author":"Radzioch","year":"2015","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0114|cit114","first-page":"289","article-title":"The cystic fibrosis associated fatty acid imbalance is corrected by a novel formulation of fenretinide in a phase IB clinical trial","volume":"50 Suppl 41","author":"Wojewodka","year":"2015","journal-title":"Pediatric Pulmonology"},{"issue":"4","key":"10.1002\/14651858.CD007020.pub4-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/ajcn\/75.4.668","article-title":"Increased plasma fatty acid concentrations after respiratory exacerbations are associated with elevated oxidative stress in cystic fibrosis patients","volume":"75","author":"Wood","year":"2002","journal-title":"American Journal of Clinical Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD007020.pub4-BIB0116|cit116","first-page":"36","article-title":"Use of the mucolytic agent, mucosolvin, in multiple modality treatment of cystic fibrosis in children","volume":"4","author":"Zoirova","year":"1983","journal-title":"Pediatriia"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0117|cit117","first-page":"263","article-title":"High-dose oral N-Acetylcysteine as a systemic antioxidant and potent inhibitor of lung inflammation in CF: a pilot phase 1 trial","volume":"40 Suppl 28","author":"Tirouvanziam","year":"2005","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0118|cit118","first-page":"295","article-title":"Phase 2 trial of high-dose oral N-Acetylcysteine as a systemic antioxidant and inhibitor of lung inflammation in CF","volume":"41 Suppl 29","author":"Tirouvanziam","year":"2006","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0119|cit119","first-page":"144","article-title":"Comparison of the efficacy of water-miscible and fat soluble vitamin E in the therapy of vitamin E deficiency in cystic fibrosis patients","volume":"5 Suppl 2","author":"Wong","year":"1988","journal-title":"Pediatric Pulmonology"},{"issue":"5","key":"10.1002\/14651858.CD007020.pub4-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1515\/CCLM.1999.082","article-title":"Lipid peroxidation and antioxidant defenses in cystic fibrosis patients","volume":"37","author":"Benabdeslam","year":"1999","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0121|cit121","doi-asserted-by":"crossref","unstructured":"Brown RK Kelly FJ Evidence for increased oxidative damage in patients with cystic fibrosis Pediatric Research 1994 487 93 PMID: 7816524","DOI":"10.1203\/00006450-199410000-00013"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0122|cit122","doi-asserted-by":"crossref","unstructured":"Brown RK Wyatt H Price JF Kelly FJ Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress European Respiratory Journal 1996 334 9 1996063391","DOI":"10.1183\/09031936.96.09020334"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0123|cit123","unstructured":"Canadian Cystic Fibrosis Foundation Report of the Canadian Patient Data Registry Canadian Patient Data Registry [Toronto, Ontario] 2002"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0124|cit124","unstructured":"Cystic Fibrosis Foundation Patient Registry 2005 Annual Data Report [Bethesda, Maryland] 2005"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0125|cit125","unstructured":"Cystic Fibrosis Foundation Cystic Fibrosis Foundation Patient Registry 2015 Annual Data Report Bethesda, Maryland 2016"},{"issue":"3","key":"10.1002\/14651858.CD007020.pub4-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jcf.2016.12.002","article-title":"Increasing sputum levels of gamma-glutamyltransferase may identify cystic fibrosis patients who do not benefit from inhaled glutathione","volume":"16","author":"Corti","year":"2017","journal-title":"Journal of Cystic Fibrosis"},{"issue":"8","key":"10.1002\/14651858.CD007020.pub4-BIB0127|cit127","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006751.pub5","article-title":"Vitamin A and beta (\u03b2)-carotene supplementation for cystic fibrosis","author":"Vries","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0128|cit128","unstructured":"Deeks J Higgins J Altman D Chapter 9: Analysing data and undertaking meta-analysis. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.freeradbiomed.2017.09.028","article-title":"Oxidative stress in early cystic fibrosis lung disease is exacerbated by airway glutathione deficiency","volume":"113","author":"Dickerhof","year":"2017","journal-title":"Free Radical Biology and Medicine"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0130|cit130","doi-asserted-by":"crossref","unstructured":"Dotan Y Lichtenberg D Pinchuk I Lipid peroxidation cannot be used as a universal criterion of oxidative stress Progress in Lipid Research 2004 200 27","DOI":"10.1016\/j.plipres.2003.10.001"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0131|cit131","doi-asserted-by":"crossref","unstructured":"Elbourne DR Altman DG Higgins JP Curtin F Worthington HV Vail A Meta-analyses involving cross-over trials: methodological issues International Journal of Epidemiology 2002 140 9","DOI":"10.1093\/ije\/31.1.140"},{"issue":"5","key":"10.1002\/14651858.CD007020.pub4-BIB0132|cit132","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007298.pub4","article-title":"Vitamin D supplementation for cystic fibrosis","author":"Ferguson","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0133|cit133","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.bbadis.2011.12.012","article-title":"Oxidative stress and antioxidant therapy in cystic fibrosis","volume":"5","author":"Galli","year":"2012","journal-title":"Biochimica et Biophysica acta 1822"},{"issue":"7414","key":"10.1002\/14651858.CD007020.pub4-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0135|cit135","unstructured":"Higgins JP Altman DG Sterne JA on behalf of the CSMG and the CBMG editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0136|cit136","unstructured":"Higgins JP Deeks JJ Altman DG on behalf of the CSMG editor(s) Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0137|cit137","unstructured":"Homnick D Trial information for Cochrane review [personal communication] Email to: L Shamseer"},{"issue":"1","key":"10.1002\/14651858.CD007020.pub4-BIB0138|cit138","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008482.pub4","article-title":"Vitamin K supplementation for cystic fibrosis","author":"Jagannath","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9-10","key":"10.1002\/14651858.CD007020.pub4-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0278-6915(99)00087-3","article-title":"Glutathione: in defence of the lung","volume":"37","author":"Kelly","year":"1999","journal-title":"Food and Chemical Toxicology"},{"issue":"1","key":"10.1002\/14651858.CD007020.pub4-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1183\/09031936.00170213","article-title":"Oxidation contributes to low glutathione in the airways of children with cystic fibrosis","volume":"44","author":"Kettle","year":"2014","journal-title":"European Respiratory Journal"},{"issue":"5","key":"10.1002\/14651858.CD007020.pub4-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jcf.2010.05.004","article-title":"Design and powering of cystic fibrosis clinical trials using rate of FEV1 decline as an efficacy endpoint","volume":"9","author":"Konstan","year":"2010","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0142|cit142","doi-asserted-by":"crossref","DOI":"10.4159\/9780674040243","volume-title":"Summing Up: The Science of Reviewing Research","author":"Light","year":"1984"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0143|cit143","doi-asserted-by":"crossref","unstructured":"Mayer-Hamblett N Aitken ML Accurso FJ Kronmal RA Konstan MW Burns JL Association between pulmonary function and sputum biomarkers in cystic fibrosis American Journal of Respiratory and Critical Care Medicine 2007 200609","DOI":"10.1164\/rccm.200609-1354OC"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"933S","DOI":"10.1093\/jn\/133.3.933S","article-title":"Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research","volume":"133 Suppl 3","author":"Mayne","year":"2003","journal-title":"Journal of Nutrition"},{"issue":"6","key":"10.1002\/14651858.CD007020.pub4-BIB0145|cit145","first-page":"100097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007020.pub4-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcf.2007.06.003","article-title":"Validation of the Italian version of the Cystic Fibrosis Quality of Life Questionnaire (CFQoL), a disease specific measure for adults and adolescents with cystic fibrosis","volume":"7","author":"Monti","year":"2008","journal-title":"Journal of Cystic Fibrosis"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD007020.pub4-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/ajrccm.158.5.9803102","article-title":"8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases","volume":"158","author":"Montuschi","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007020.pub4-BIB0148|cit148","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009422.pub3","article-title":"Vitamin E supplementation in people with cystic fibrosis","author":"Okebukola","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD007020.pub4-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1172\/JCI29444","article-title":"S-nitrosothiols signal hypoxia-mimetic vascular pathology","volume":"117","author":"Palmer","year":"2007","journal-title":"Journal of Clinical Investigation"},{"issue":"5","key":"10.1002\/14651858.CD007020.pub4-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests. Series \u2018\u2018ATS\/ERS Task Force: Standardisation of lung function testing\u2019\u2019. Number 5 in this series","volume":"26","author":"Pellegrino","year":"2005","journal-title":"European Respiratory Journal"},{"issue":"2","key":"10.1002\/14651858.CD007020.pub4-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1753-4887.2000.tb07810.x","article-title":"Beta carotene: from biochemistry to clinical trials","volume":"58","author":"Pryor","year":"2000","journal-title":"Nutrition Reviews"},{"issue":"5","key":"10.1002\/14651858.CD007020.pub4-BIB0152|cit152","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1152\/physiol.00013.2017","article-title":"Both ways at once: keeping small airways clean","volume":"32","author":"Quinton","year":"2017","journal-title":"Physiology"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0153|cit153","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1742-4682-5-8","article-title":"A mathematical model of glutathione metabolism","volume":"5","author":"Reed","year":"2008","journal-title":"Theoretical Biology & Medical Modelling"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD007020.pub4-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1164\/ajrccm.156.2.9611013","article-title":"Oxidative stress in Chronic Obstructive Pulmonary Disease","volume":"156","author":"Repine","year":"1997","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0155|cit155","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"7","key":"10.1002\/14651858.CD007020.pub4-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0002-8223(96)00190-3","article-title":"Update on the biological characteristics of the antioxidant micronutrients vitamin C, vitamin E, and the carotenoids","volume":"96","author":"Rock","year":"1996","journal-title":"Journal of the Americal Dietetic Association"},{"issue":"6","key":"10.1002\/14651858.CD007020.pub4-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1152\/jappl.1993.75.6.2419","article-title":"Systemic deficiency of glutathione in cystic fibrosis","volume":"75","author":"Roum","year":"1993","journal-title":"Journal of Applied Physiology"},{"issue":"2","key":"10.1002\/14651858.CD007020.pub4-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pharmthera.2013.09.006","article-title":"Existing and potential therapeutic uses for n-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits","volume":"141","author":"Rushworth","year":"2014","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD007020.pub4-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.redox.2015.07.012","article-title":"Effects of N-acetylcysteine, oral glutathione (GSH) and a novel sublingual form of GSH on oxidative stress markers: A comparative crossover study","volume":"6","author":"Schmitt","year":"2015","journal-title":"Redox Biology"},{"issue":"11","key":"10.1002\/14651858.CD007020.pub4-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/oxfordjournals.aje.a009220","article-title":"Oxidative stress and lung function","volume":"146","author":"Schunemann","year":"1997","journal-title":"American Journal of Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD007020.pub4-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jcf.2014.09.015","article-title":"The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa infection - A pilot study","volume":"14","author":"Skov","year":"2015","journal-title":"Journal of Cystic Fibrosis"},{"issue":"5","key":"10.1002\/14651858.CD007020.pub4-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jpeds.2009.05.005","article-title":"Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening","volume":"155","author":"Stick","year":"2009","journal-title":"Journal of Pediatrics"},{"issue":"7","key":"10.1002\/14651858.CD007020.pub4-BIB0163|cit163","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007168.pub3","article-title":"Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis","author":"Tam","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD007020.pub4-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1073\/pnas.0511304103","article-title":"High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis","volume":"103","author":"Tirouvanziam","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1002\/14651858.CD007020.pub4-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1022011704399","article-title":"The revised German Cystic Fibrosis Questionnaire: validation of a disease-specific health-related quality of life instrument","volume":"12","author":"Wenninger","year":"2003","journal-title":"Quality of Life Research"},{"issue":"395","key":"10.1002\/14651858.CD007020.pub4-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1651-2227.1994.tb13229.x","article-title":"Oxygen free radicals and antioxidants in cystic fibrosis: the concept of an oxidant-antioxidant imbalance","volume":"83","author":"Winklhofer-Roob","year":"1994","journal-title":"Acta Paediatrica"},{"issue":"2","key":"10.1002\/14651858.CD007020.pub4-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/07315724.2001.10719028","article-title":"Oxidative stress in cystic fibrosis: Dietary and metabolic factors","volume":"20","author":"Wood","year":"2001","journal-title":"Journal of the American College of Nutrition"},{"issue":"8","key":"10.1002\/14651858.CD007020.pub4-BIB0168|cit168","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007020.pub3","article-title":"Antioxidant supplementation for lung disease in cystic fibrosis","author":"Ciofu","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD007020.pub4-BIB0169|cit169","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007020.pub2","article-title":"Antioxidant micronutrients for lung disease in cystic fibrosis","author":"Shamseer","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007020.pub4\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T05:19:17Z","timestamp":1676524757000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007020.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,3]]},"references-count":169,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007020.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,3]]}}}